Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
暂无分享,去创建一个
Jianjun Gao | Zhenxue Tian | Xu Yang | Jianjun Gao | Zhenxue Tian | Xu Yang
[1] Hongzhou Lu,et al. Drug treatment options for the 2019-new coronavirus (2019-nCoV). , 2020, Bioscience trends.
[2] M. Toumi,et al. Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al , 2020, Journal of market access & health policy.
[3] A. Cassone,et al. Effects of chloroquine on viral infections: an old drug against today's diseases , 2003, The Lancet Infectious Diseases.
[4] G. Rada,et al. Living evidence in response to controversies about the use of antimalarials in COVID-19 , 2020, Revista Española de Cardiología (English Edition).
[5] Md. Imtaiyaz Hassan,et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach , 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[6] Safeera Khan,et al. Pathological Findings and Management of COVID-19 Patients: A Brief Overview of Modern-day Pandemic , 2020, Cureus.
[7] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[8] Chengyu Jiang,et al. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model , 2012, Cell Research.
[9] Cindy B. Yeoh,et al. COVID-19 in the Cancer Patient , 2020, Anesthesia and analgesia.